Creatinine Testing Market
Creatinine Testing Market Forecast, Trend Analysis & Competition Tracking - Global Review 2021 to 2031
Analysis of Creatinine Testing market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Creatinine Testing Market: Market Outlook
Creatinine testing involves the measurement of the level of creatinine, which is a product of muscle creatine catabolism and is thus a reliable indicator of kidney function by an indication that a rise in the level of creatinine may indicate Acute Kidney Injury or Chronic Kidney Disease.
According to the latest research by Fact.MR., the creatinine testing market is set to witness significant growth during 2021-2031. Demand for creatinine testing will appear to be higher in emerging economies for early diagnosis and due to the increasing number of advanced and viable technologies in the creatinine testing market. A shift towards novel biomarkers will mean limited opportunities in near future, as current methods are based on the levels of serum creatinine and blood urea. The serum creatinine lacks high predictive value, which can be addressed with the use of novel biomarkers. However, a rise in the R&D initiatives in creatinine testing for the development of novel products will be responsible for a significant upsurge in the market growth of creatinine testing products over the forecast period.
What is Driving Demand for Creatinine Testing?
The new advancements in Kidney Function Testing have increased the product demand for creatinine testing. The increasing prevalence of diabetes and hypertension in the growing geriatric population causing a rise in the risk of Chronic Kidney Disease and Acute Kidney Injury has resulted in an increment in demand for creatinine testing products and acts as a promotional factor in the segment growth over the forecast period. Apart from these factors, the investments by market players and increased R&D activities and rising government initiatives are anticipated to induce creatinine testing market growth significantly.
Prevalence of Chronic Kidney Disease Likely to Augment Creatinine Testing Product Sales
There is a global rise in the geriatric population, thus leading to a significant rise in the prevalence of chronic kidney disease in the risk groups, which is one of the main causes of death across the globe. Through the induction of the COVID-19 pandemic, the patients infected with the COVID-19 virus and hospitalized are likely to develop acute kidney infections. They are at even greater risk of developing chronic kidney disease, thus calling for a significant surge in the demand for creatinine testing products to monitor the creatinine ratio and to counter risk factors associated with renal disorders. Further, the advancements in the testing of kidney functions through the level of creatinine define an absolute rise in the demand for creatinine testing products. Apart from these factors, several government initiatives to control chronic kidney diseases, such as the Chronic Kidney Disease initiative by the CDC, collaboration of the National Kidney Disease Education Program with the European Federation of Clinical Chemistry to establish the Creatinine Standardization Program and the National Dialysis Program by the government of India, to detect Chronic Kidney Disease and test the creatinine ratios have augmented the demand for creatinine testing products.
The US and Canada Creatinine Testing Market Outlook
The US is one of the largest markets for creatinine testing globally. The US creatinine testing market is set to persist its dominating grasp on the creatinine testing market globally during the forecast period of 2021-2031. The US has observed a rapid growth in the past few years in the creatinine measurement market and it is anticipated to lead the creatinine measurement market across North America during the forecast period. The demand for creatinine testing in the US and Canada will be led by the increasing geriatric population with risk of diabetes, hypertension and subsequent renal disorders including acute kidney infections and chronic kidney disease. Due to the rising development in the healthcare sector, research related to creatinine testing has displayed an increase in terms of its evaluation of point-of-care creatinine testing for rapid results. The demand for creatinine testing in the US and Canada will be led by the Rapid Urine Tests Segment which is projected to display the highest growth rate during the forecast period. Other factors catering to the growth are the strong presence of healthcare industry leaders and the reimbursement scenario.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Europe Demand Outlook for Creatinine Testing
The European market is expected to register a steady growth during the forecast period. The factors that would aid this growth are the change in healthcare policies that allow smooth monitoring of renal disorders, the presence of sophisticated healthcare infrastructure and a prompt acquisition of advanced diagnostic methods in healthcare settings. The high prevalence of population in Europe suffering from Acute Kidney Infection and Chronic kidney disease has led to the adoption of creatinine testing products and has hence led to an emerging market in Europe.
Who are the Key Manufacturers and Suppliers of Creatinine Testing?
Some of the leading manufacturers and suppliers of creatinine testing include
- Beijing Jiuqiang Biotechnology Co. Ltd.
- Siemens AG
- Nova Biomedical
- Thermo Fisher Scientific Inc.
- Randox Laboratories
- URIT Medical Electronic Co. Ltd.
- Abcam PLC
- MedTest Holdings Inc. (Pointe Scientific Inc.)
- Danaher Corporation
- F. Hoffmann-la Roche Ltd
- DiaSys Diagnostic Systems GmbH
- Dialab GmbH
- Sentinel Ch. Spa.
- Wako Pure Chemical Industries Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd
- Maccura Biotechnology
Abbott adopts the key strategy of acquisitions to make a strong market presence in addition to the expansion of its product portfolio. It is a leading player across the globe with a strong presence in over 160 countries.
Danaher Corporation is another major player in the creatinine testing market with a strong presence in the diagnostics market and has opted for the key strategy of product launches and partnerships to make a strong product portfolio and maintain its presence in the market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Creatinine Testing Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
By Test Type
- Urine Tests
- Urine Albumin Tests
- Urine Creatinine Tests
- Glycated Albumin
- Blood & Serum Creatinine Tests
By Product Type
- Cartridges for POC Analyzers
- Cartridges for Table-Top Analyzers
- Dipsticks & Kits
- Urinary Tract Obstruction
- Renal Failure
- Kidney Cancer
- Hospitals & Clinics’
- Diagnostic Laboratories
- Research Laboratories & Institutes
- North America
- Latin America
- The U.K.
- South Asia
- Rest of Asia Pacific
- East Asia
- South Korea
- The Middle East and Africa
- GCC Countries
- South Africa
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- FAQs -
The creatinine testing market is likely to be worth US$ 1297.11 Million in 2022.
The creatinine testing market has high growth potential due to the rising prevalence of kidney disorders
The manufacturers in the creatinine testing industry are likely to find the most opportunities in the North Amercian region.